IMPLANTABLE NANOCHANNEL DELIVERY DEVICES

Research output: Patent

Alessandro Grattoni (Inventor), Edward Brian Butler (Inventor), Ganesh Palapattu (Inventor)

An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.

Original languageEnglish (US)
Patent numberUS2018125780
IPCA61M 37/ 00 A I
Priority date5/16/16
StatePublished - May 10 2018

Cite this

Standard

IMPLANTABLE NANOCHANNEL DELIVERY DEVICES. / Grattoni, Alessandro (Inventor); Butler, Edward Brian (Inventor); Palapattu, Ganesh (Inventor).

IPC No.: A61M 37/ 00 A I. Patent No.: US2018125780.

Research output: Patent

Harvard

Grattoni, A, Butler, EB & Palapattu, G 2018, IMPLANTABLE NANOCHANNEL DELIVERY DEVICES, Patent No. US2018125780, IPC No. A61M 37/ 00 A I.

APA

Grattoni, A., Butler, E. B., & Palapattu, G. (2018). IPC No. A61M 37/ 00 A I. IMPLANTABLE NANOCHANNEL DELIVERY DEVICES. (Patent No. US2018125780).

Vancouver

Grattoni A, Butler EB, Palapattu G, inventors. IMPLANTABLE NANOCHANNEL DELIVERY DEVICES. A61M 37/ 00 A I. 2018 May 10.

Author

Grattoni, Alessandro (Inventor) ; Butler, Edward Brian (Inventor) ; Palapattu, Ganesh (Inventor). / IMPLANTABLE NANOCHANNEL DELIVERY DEVICES. IPC No.: A61M 37/ 00 A I. Patent No.: US2018125780.

BibTeX

@misc{70787f7867eb442bba9fab0bb75fa085,
title = "IMPLANTABLE NANOCHANNEL DELIVERY DEVICES",
abstract = "An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.",
author = "Alessandro Grattoni and Butler, {Edward Brian} and Ganesh Palapattu",
year = "2018",
month = "5",
day = "10",
language = "English (US)",
type = "Patent",
note = "US2018125780; A61M 37/ 00 A I",

}

RIS

TY - PAT

T1 - IMPLANTABLE NANOCHANNEL DELIVERY DEVICES

AU - Grattoni, Alessandro

AU - Butler, Edward Brian

AU - Palapattu, Ganesh

PY - 2018/5/10

Y1 - 2018/5/10

N2 - An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.

AB - An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.

M3 - Patent

M1 - US2018125780

ER -

Similar Experts

Similar Research Outputs Profiled Experts

Similar research outputs

Similar Research Outputs

  1. IMPLANTABLE NANOCHANNEL DELIVERY DEVICES

    Grattoni, A., Butler, E. B. & Palapattu, G., Nov 24 2016, IPC No. A61M 37/ 00 A I, Patent No. WO2016187100, Priority date May 15 2015, Priority No. US201562161986P

    Research output: Patent

  2. Nanochannel implants for minimally-invasive insertion and intratumoral delivery

    Hood, R. L., Bruno, G., Jain, P., Anderson, J., Wolfe, T., Quini, C., Schmulen, J., Li, X. C., Butler, E. B., Krishnan, S. & Grattoni, A., Oct 1 2016, In : Journal of Biomedical Nanotechnology. 12, 10, p. 1907-1915 9 p.

    Research output: Contribution to journalArticle

ID: 42510741